Clinical Trial Update: Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris [Phase 4]

View source ↗

Summary

Phase 4 trial update on Yangxin Shengmai Granules for stable angina in coronary heart disease, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Stable Angina Pectoris

Drugs mentioned

• Yangxin Shengmai Granules

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Coronary Heart Disease, Stable Angina | Phase 4 | Status: UNKNOWN